Source: Annual Congress 2004 - Animal models of lung injury and repair
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Vlahos, S. Bozinovski, J. E. Jones, M. Hansen, L. Irving, G. P. Anderson (Victoria, Australia). Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model. Eur Respir J 2004; 24: Suppl. 48, 738

Member's Comments

No comment yet.

Related content which might interest you: Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Searching for inflammatory and oxidative-stress markers capable of clustering severe asthma. Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Using transcriptomics to understand the potential functions of lung function associated gene, GPR126 in human airway smooth muscle cells Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Identification of novel susceptibility genes in ozone-induced inflammation in mice Source: Eur Respir J 2010; 36: 428 Year: 2010 To the molecular genetic mechanisms of the COPD pathogenesis Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013